GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed Feb 28, 2019
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2019-02-26$3.65/sh−200,000$730,000→ 9,385,848 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning.